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AntimicrobialAbstract A convenient, one-pot, multi-component protocol for the preparation of 2-(1-(2-oxo-2H-
chromen-3-yl)ethylidene)hydrazinecarbothioamide derivatives has been achieved. Here, firstly we
have reported the synthesis of 3-acetyl-2H-chromen-2-one using starch sulfuric acid and cellulose
sulfuric acid as biodegradable catalysts. Subsequently, we also carried out the reaction of isothio-
cynates, hydrazine hydrate and 3-acetyl-2H-chromen-2-one in the presence of catalytic amount of
glacial acetic acid in refluxing ethanol to afford corresponding 2-(1-(2-oxo-2H-chromen-3-yl)ethyli
dene)hydrazinecarbothioamide derivatives in high to excellent yields. All synthesized compounds
were screened for antimicrobial activity. All compounds were found to show good to excellent activ-
ity against Escherichia coli MTCC 443.
 2016 University of Bahrain. Production and Hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The design and green synthesis of biological active compounds
as well as drug intermediates in the field of medicinal chemistry
can be considered as an attractive research option, because
these syntheses have various benefits such as waste reduction,
energy savings, atom economy, easy work-up processes and
avoiding the use of hazardous chemicals. (Kumar et al.,
2012; Anastas and Kirchhoff, 2002). The development of a
green, clean and eco-friendly reaction methodology for thepreparation of highly potent biological active compounds is
an interesting and to be explored area of medicinal chemistry
(Vekariya and Patel, 2015). Multi-component reactions
(MCRs) have been shown to be powerful tools in the field of
green chemistry for developing various medicinally important
scaffolds and intermediates (Chanda and Fokin, 2009).
Coumarin derivatives are an important class of heterocy-
cles, which occupy an important place in the domain of natural
products and synthetic organic chemistry (Vekariya and Patel,
2014). A wide range of organic compounds containing the cou-
marin moiety have also been found to exhibit many useful
applications, which include antibacterial (Fan et al., 2001),
antifungal (Zaha and Hazem, 2002), antioxidant (Vazquez-
Rodriguez et al., 2013), analgesic (Khode et al., 2009),antimi-
2 R.H. Vekariya et al.anticancer (Wu et al., 2014), anti-HIV (Bhavsar et al., 2011),
anti-inflammatory (Timonen et al., 2011), antibiotic
(Chimenti et al., 2006), anticoagulant (Van Schie et al., 2009)
and antitumor (Gouda et al., 2012). Some synthetic analogs
of 3-substituted coumarin derivatives (Fig. 1I and II) were
reported in the literature. They shows antibacterial and anti-
convulsant activities respectively (Chimenti et al., 2010).
Thiosemicarbazone derivatives, a large group of thiourea
derivatives, exhibit various biological activities and have there-
fore attracted considerable pharmaceutical interest (Hu et al.,
2006). They have been evaluated over the last 50 years as
antiviral (Garcia et al., 2003), antibacterial (Kasuga et al.,
2003), anticancer agents (Dilovic et al., 2008), anti-malarial
(Divatia et al., 2014), anti-HIV (Patel et al., 2013), whose bio-
logical activities are a function of the parent aldehyde or
ketone moiety (Yuan et al., 2004). Moreover, compounds with
thiosemicarbazone structure are known to possess tranquiliz-
ing, analgesic, hypnotic, anti-tumor, anti-depressant, muscle
relaxing, anti-fungal and anti-inflammatory properties
(Beraldo and Gambinob, 2004; Singh et al., 2006, 2005).
Indeed, many thiosemicarbazones exhibit promising anti-
protozoan activity through the inhibition of cysteine proteases
and other targets (Chiyanzu et al., 2003; Greenbaum et al.,
2004; Fujii et al., 2005). Heterocyclic thiosemicarbazones are
important because of their possible beneficial biological activ-
ity (El-Sharief and Moussa, 2009). Some synthetic analogs of
thiosemicarbazone already exist in the market like, Triapine
and Marboran (Fig. 1III and IV). Triapine (3-aminopyri
dine-2-carboxaldehyde thiosemicarbazone) is a potent ribonu-
cleotide reductase inhibitor and is used in the treatment of can-
cer (Tsimberidou et al., 2002). Marboran (1-N-methylisatin-b-
thiosemicarbazone) is a good anti-viral agent. It has activity
against Pox viruses, Maloney leukemia viruses and recently
against HIV (Sebastian et al., 2008).N
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Figure 1 Design of novel coumarin hybrid thiosemicarbazone
derivatives.
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crobial evolution. Journal of the Association of Arab Universities for Basic and ApDespite many significant progresses in antimicrobial ther-
apy, infectious diseases caused by bacteria and fungi remain
a major worldwide health problem due to rapid development
of resistance to the existing antibacterial and antifungal drugs.
Thiosemicarbazone derivatives have been the focus of medici-
nal chemists because of their potential biological activities
(Tsimberidou et al., 2002). Thiosemicarbazones were studied
for their antibacterial and antifungal properties (Chohan
et al., 2005). Recently, many of these derivatives were synthe-
sized and described for their activity against bacterial species;
and this can indicate that many derivatives, in-between, are
useful in the therapy, prophylaxis of bacterial infections and
can represent a template for the development of novel antibac-
terial drugs (Bermudez et al., 2003; Sriram et al., 2006).
Organic transformations using cellulose sulfuric acid (CSA)
and starch sulfuric acid (SSA) have many advantages such as a
simple work-up process, inexpensive catalyst, eco-friendliness,
reusable catalyst, excellent yield of the products with high pur-
ity and shorter reaction times (Vekariya and Patel, 2015). The
CSA and SSA are solid, bio-degradable catalysts and after
completion of organic transformation, can be recovered and
reused several times without loss of its efficiency. Various cat-
alysts have been developed such as piperidine, L-lysine, L-
proline, KSF-Clay, HZSM-5 Zeolite, heteropoly acids,
ZrOCl28H2O, SnCl22H2O, Ionic liquids and cellulose sul-
fonic acid for the synthesis of 3-acetyl coumarin via Knoeve-
nagel condensation (Vekariya and Patel, 2014). Thus, it was
thought worthwhile to develop a new and mild method for
the synthesis of 3-acetyl coumarin using SSA and CSA as inex-
pensive biopolymer-based catalysts.
Therefore, it was aimed in the present investigation to syn-
thesize and characterize newer coumarin hybrid thiosemicar-
bazone derivatives for their expected antimicrobial activities.
Herein, we report an efficient and green synthesis of 3-acetyl
coumarin from the reaction of 2-hydroxy benzaldehyde and
ethyl acetoacetate in the presence of SSA and CSA under
solvent-free conditions at 100 C. Finally we have synthesized
coumarin hybrid thiosemicarbazone derivatives via one-pot
reaction of a variety of isothiocynates, hydrazine hydrate
and 3-acetyl coumarin in the presence of a catalytic amount
of AcOH under refluxing ethanol (Scheme 1).
2. Experimental section
All the analytical grade reagents and starting materials were
used. Melting points are uncorrected and were determined in
automatic melting point apparatus named Optimelt MPA
100. TLC was run on Aluminum precoated ready-made thin
layer chromatography (TLC) silica gel 60 F254 plate (Merck,
Germany) and visualization was done using iodine or UV
light. IR Spectra (V max in cm1) were recorded on a
Perkin-Elmer FT-IR 377 spectrophotometer using KBr. Pro-
ton NMR spectra were recorded on Bruker AV 400 MHz spec-
trometer using DMSO as solvent and TMS as the internal
reference. Mass spectra were recorded at Advion expression
CMS, USA, Acetone is used as mobile phase, electron spray
ionization (ESI) is used as ion source. Elemental analysis
was performed on a CHN elemental analyzer. Starch sulfuric
acid (SSA) and cellulose sulfuric acid (CSA) were prepared
according to previously reported procedure (Shaabani et al.,
2008).t synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimi-
plied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.04.002
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Scheme 1 Synthetic protocol of novel coumarin-thiosemicar-
bazone derivatives.
Synthesis and evolution of coumarin hybrid thiosemicarbazone derivatives 32.1. Typical procedure for the preparation of 3-acetyl-2H-
chromen-2-one
A mixture of ortho-hydroxy benzaldehyde (1.0 mmol) and
ethyl acetoacetate (1.0 mmol) and CSA or SSA (40 mg) was
stirred at 100 C temperature under solvent free conditions
for 4 h. The reaction progress was monitored by TLC using
hexane:ethyl acetate (4:6) as the mobile phase. After comple-
tion of the reaction, the reaction mixture was mixed with hot
ethanol (5 ml) and filtered. SSA and CSA were recovered by
filtration after the addition of ethanol to the stirred reaction
mixture. Conventional elemental analysis showed the presence
of sulfur, indicating sulfur had not leached out. Filtrate was
cooled in ice to obtain pale yellow colored 3-acetyl coumarin
with 95% yield; m.p. = 120–122 C. 1H NMR (400 MHz,
DMSO-d6, d ppm, J Hz) 2.58 (S, 3H, ACOCH3), 7.44–7.78
(m, 4H, Ar-H), 8.64 (s, 1H, pyran-H). MS: m/z (%) 389.24
(M++1, 100%) base peak.
2.2. General procedure for the one-pot preparation of 3-
acetylcoumarin thiosemicarbazone derivatives (1–19)
A solution of hydrazine hydrate (1.5 mmol, 80%) in ethanol
(5 ml) was added drop wise to a stirred solution of isothiocy-
nates (1.0 mmol) in ethanol (5 ml) at room temperature. A
white precipitate starts to form immediately upon addition,
the stirring was continued for 30 min. Now, 3-acetyl-2H-
chromen-2-one (1.0 mmol) in ethanol (10 ml) was added into
the reaction mixture and heated at 75–80 C. Then, add
20 mol% of glacial acidic to the reaction mixture. The reaction
mixture was refluxed for 4 h. Reaction progress was monitored
on a ready-made TLC plate (Merck) every 30 min. using hex-
ane: ethyl acetate (4:6) as the solvent system. After completion
of the reaction, the reaction mixture was cooled, water was
added and a yellow precipitate started to form; the solid was
filtered and washed with water then with ethanol. The product
was recrystallized from ethanol and dried under vacuum,
which afforded the pure analytical sample in excellent yields.
2.2.1. N-(4-nitrophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (1)
IR (KBr) cm1: 3419, 3330 (NH), 1720 (C‚O), 1630 (C‚N),
1613, 1588 (C‚S), 1375 (C‚S), 1120, 1095 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 3.74 (S, 3H, CH3), 7.18–
8.09 (m, 8H, Ar-H), 8.60 (S, 1H, pyran-H), 10.49 (S, 1H,
NH), 11.23 (S, 1H, NH). MS: m/z (%) 383.3 (M++1,
100%) base peak. Elemental analysis: Calc. for C18H14N4O4SPlease cite this article in press as: Vekariya, R.H. et al., A one pot, three componen
crobial evolution. Journal of the Association of Arab Universities for Basic and Ap(382.39) C, 56.54%; H, 3.69%; N, 14.65%; S, 8.39%, found:
C, 56.38%; H, 3.50%; N, 14.43%; S, 8.52%.
2.2.2. N-(4-chlorophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (2)
IR (KBr) cm1: 3408, 3335 (NH), 1722 (C‚O), 1642 (C‚N),
1618, 1595 (C‚S), 1367 (C‚S), 1107, 1085 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.34 (S, 3H, CH3), 7.38–
7.80 (m, 8H, Ar-H), 8.48 (S, 1H, pyran-H), 10.21 (S, 1H,
NH), 10.99 (S, 1H, NH). MS: m/z (%) 370.3 (M+1, 100%)
base peak, 372.2 (M++2, 62%). Elemental analysis: Calc.
for C18H14ClN3O2S (371.84) C, 58.14%; H, 3.79%; N,
11.30%; S, 8.62%, found: C, 58.38%; H, 3.57%; N, 11.41%;
S, 8.55%.
2.2.3. 2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)-N-(p-tolyl)
hydrazinecarbothioamide (3)
IR (KBr) cm1: 3428, 3332 (NH), 1718 (C‚O), 1633 (C‚N),
1610, 1598 (C‚S), 1371 (C‚S), 1102, 1088 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.31 (S, 3H, 4-CH3), 2.51
(S, 3H, CH3), 7.21–8.09 (m, 8H, Ar-H), 8.51 (S, 1H, pyran-H),
10.03 (S, 1H, NH), 10.83 (S, 1H, NH). MS: m/z (%) 352.3
(M++1, 100%) base peak, 353.3 (M++2, 54%). Elemental
analysis: Calc. for C19H17N3O2S (351.42) C, 64.94%; H,
4.88%; N, 11.96%; S, 9.12%, found: C, 64.98%; H, 4.87%;
N, 11.81%; S, 9.22%.
2.2.4. 2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)-N-
propylhydrazinecarbothioamide (4)
IR (KBr) cm1: 3429, 3331 (NH), 1715 (C‚O), 1637 (C‚N),
1609, 1594 (C‚S), 1372 (C‚S), 1111, 1091 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 1.58 (t, 3H, CH3, J= 10),
1.90 (q, 2H, CH2), 3.35 (S, 3H, CH3), 3.73 (S, 1H, NH), 6.85–
7.86 (m, 4H, Ar-H), 8.24 (S, 1H, pyran-H), 10.44 (S, 1H, NH).
MS: m/z (%) 304.5 (M++1, 100%) base peak, 305.5 (M++2,
27%). Elemental analysis: Calc. for C15H17N3O2S (303.38) C,
59.38%; H, 5.65%; N, 13.85%; S, 10.57%, found: C, 59.32%;
H, 5.67%; N, 13.88%; S, 10.49%.
2.2.5. N-(3,4-dichlorophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (5)
IR (KBr) cm1: 3415, 3332 (NH), 1723 (C‚O), 1636 (C‚N),
1617, 1582 (C‚S), 1378 (C‚S), 1128, 1099 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.51 (S, 3H, CH3), 7.40–
8.04 (m, 8H, Ar-H), 8.47 (S, 1H, pyran-H), 10.29 (S, 1H,
NH), 11.18 (S, 1H, NH). MS: m/z (%) 405.1 (M+1, 100%)
base peak, 407.1 (M++2, 86%). Elemental analysis: Calc.
for C18H13Cl2N3O2S (406.29) C, 53.21%; H, 3.23%; N,
10.34%; S, 7.89%, found: C, 53.32%; H, 3.43%; N, 10.58%;
S, 7.69%.
2.2.6. N-(tert-butyl)-2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)
hydrazinecarbothioamide (6)
IR (KBr) cm1: 3423, 3333 (NH), 1720 (C‚O), 1627 (C‚N),
1615, 1593 (C‚S), 1378 (C‚S), 1124, 1101 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.3 (S, 9H, t-butyl), 3.35
(S, 3H, CH3), 7.18–8.09 (m, 4H, Ar-H), 8.55 (S, 1H, pyran-
H), 10.03 (S, 1H, NH), 10.90 (S, 1H, NH). MS: m/z (%)
318.1 (M++1, 100%) base peak, 319.1 (M++2, 26%). Ele-
mental analysis: Calc. for C16H19N3O2S (317.41) C, 50.54%;t synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimi-
plied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.04.002
4 R.H. Vekariya et al.H, 6.03%; N, 13.24%; S, 10.10%, found: C, 50.37%; H,
6.14%; N, 13.38%; S, 10.16%.
2.2.7. N-benzyl-2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)
hydrazinecarbothioamide (7)
IR (KBr) cm1: 3415, 3337 (NH), 1723 (C‚O), 1638 (C‚N),
1619, 1579 (C‚S), 1377 (C‚S), 1129, 1092 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, JHz) 1.95 (S, 2H, CH2), 2.29 (S,
3H, CH3), 4.85 (S, 2H, CH2), 6.82–8.43 (m, 9H, Ar-H), 9.09 (S,
1H, pyran-H), 10.09 (S, 1H, NH). MS: m/z (%) 352.4 (M++1,
100%) base peak, 353.5 (M++2, 56%). Elemental analysis:
Calc. for C19H17N3O2S (351.42) C, 64.94%; H, 4.88%; N,
11.96%; S, 9.12%, found: C, 64.97%; H, 4.94%; N, 11.89%;
S, 9.15%.
2.2.8. N-(4-methoxyphenyl)-2-(1-(2-oxo-2H-chromen-3 yl)
ethylidene)hydrazinecarbothioamide (8)
IR (KBr) cm1: 3418, 3331 (NH), 1721 (C‚O), 1629 (C‚N),
1615, 1590 (C‚S), 1377 (C‚S), 1125, 1098 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.5 (S, 3H, CH3), 3.34 (S,
3H, OCH3), 6.90–8.60 (m, 4H, Ar-H), 9.08 (S, 1H, pyran-H),
9.55 (S, 1H, NH), 11.22 (S, 1H, NH). MS: m/z (%) 368.5
(M++1, 100%) base peak, 369.5 (M++2, 21%). Elemental
analysis: Calc. for C19H17N3O3S (367.42) C, 62.11%; H,
4.66%; N, 11.44%; S, 8.73%, found: C, 62.27%; H, 4.84%;
N, 11.39%; S, 8.68%.
2.2.9. N-(4-iodophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (9)
IR (KBr) cm1: 3414, 3327 (NH), 1728 (C‚O), 1635 (C‚N),
1614, 1587 (C‚S), 1379 (C‚S), 1128, 1092 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.27 (S, 3H, CH3), 7.06–
8.09 (m, 8H, Ar-H), 8.48 (S, 1H, pyran-H), 10.19 (S, 1H,
NH), 11.00 (S, 1H, NH). MS: m/z (%) 464.2 (M++1,
100%) base peak, 463.2 (M++2, 37%). Elemental analysis:
Calc. for C18H14IN3O2S (463.29) C, 46.66%; H, 3.05%; N,
9.07%; S, 6.92%, found: C, 46.60%; H, 3.15%; N, 9.19%;
S, 6.88%.
2.2.10. N-(3,5-dichlorophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (10)
IR (KBr) cm1: 3414, 3334 (NH), 1726 (C‚O), 1637 (C‚N),
1615, 1579 (C‚S), 1377 (C‚S), 1129, 1099 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.22 (S, 3H, CH3), 6.85–
7.84 (m, 10H, Ar-H), 8.47 (S, 1H, pyran-H), 10.31 (S, 1H,
NH), 11.19 (S, 1H, NH). MS: m/z (%) 405.1 (M+1, 100%)
base peak, 407.1 (M++2, 66%). Elemental analysis: Calc.
for C18H13Cl2N3O2S (406.29) C, 53.21%; H, 3.23%; N,
10.34%; S, 7.89%, found: C, 53.29%; H, 3.19%; N, 10.37%;
S, 7.85%.
2.2.11. N-(2-methoxyphenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (11)
IR (KBr) cm1: 3424, 3335 (NH), 1725 (C‚O), 1636 (C‚N),
1618, 1594 (C‚S), 1378 (C‚S), 1125, 1098 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, JHz) 2.51 (S, 3H, CH3), 3.81 (S,
3H, OCH3), 6.94–8.23 (m, 8H, Ar-H), 8.43 (S, 1H, pyran-H),
10.08 (S, 1H, NH), 11.23 (S, 1H, NH). MS: m/z (%) 367.3
(M++1, 100%) base peak, 368.3 (M++2, 27%). Elemental
analysis: Calc. for C19H17N3O3S (367.42) C, 62.11%; H,Please cite this article in press as: Vekariya, R.H. et al., A one pot, three componen
crobial evolution. Journal of the Association of Arab Universities for Basic and Ap4.66%; N, 11.44%; S, 8.73%, found: C, 62.10%; H, 4.69%;
N, 11.37%; S, 8.83%.
2.2.12. N-(3-methoxyphenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (12)
IR (KBr) cm1: 3422, 3333 (NH), 1723 (C‚O), 1634 (C‚N),
1616, 1590 (C‚S), 1378 (C‚S), 1125, 1100 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, JHz) 2.50 (S, 3H, CH3), 3.76 (S,
3H, OCH3) 6.75–7.81 (m, 8H, Ar-H), 8.50 (S, 1H, pyran-H),
10.07 (S, 1H, NH), 10.92 (S, 1H, NH). MS: m/z (%) 367.2
(M++1, 100%) base peak, 368.2 (M++2, 22%). Elemental
analysis: Calc. for C19H17N3O3S (367.42) C, 62.11%; H,
4.66%; N, 11.44%; S, 8.73%, found: C, 62.18%; H, 4.74%;
N, 11.42%; S, 8.80%.
2.2.13. 2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)-N-(3,4,5-
trichlorophenyl)hydrazinecarbothioamide (13)
IR (KBr) cm1: 3414, 3339 (NH), 1728 (C‚O), 1632 (C‚N),
1617, 1589 (C‚S), 1378 (C‚S), 1129, 1098 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.42 (S, 3H, CH3), 7.05–
8.08 (m, 6H, Ar-H), 8.48 (S, 1H, pyran-H), 10.05 (S, 1H,
NH), 10.43 (S, 1H, NH). MS: m/z (%) 367.2 (M++1,
100%) base peak, 368.2 (M++2, 22%). Elemental analysis:
Calc. for C18H12 Cl3N3O2S (440.73) C, 49.05%; H, 2.74%;
N, 9.53%; S, 7.28%, found: C, 49.09%; H, 2.86%; N,
9.46%; S, 7.35%.
2.2.14. N-(2,4-dichlorophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (14)
IR (KBr) cm1: 3422, 3327 (NH), 1728 (C‚O), 1633 (C‚N),
1615, 1589 (C‚S), 1377 (C‚S), 1122, 1097 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.51 (S, 3H, CH3), 6.89–
7.95 (m, 7H, Ar-H), 8.45 (S, 1H, pyran-H), 10.11 (S, 1H,
NH), 11.17 (S, 1H, NH). MS: m/z (%) 406.5 (M+, 100%) base
peak, 407.5 (M++1, 22%). Elemental analysis: Calc. for
C18H12 Cl3N3O2S (406.29) C, 53.21%; H, 3.23%; N,
10.34%; S, 7.89%, found: C, 53.19%; H, 3.26%; N, 10.43%;
S, 7.80%.
2.2.15. N-(2,4-difluorophenyl)-2-(1-(2-oxo-2H-chromen-3-yl)
ethylidene)hydrazinecarbothioamide (15)
IR (KBr) cm1: 3418, 3329 (NH), 1718 (C‚O), 1633 (C‚N),
1611, 1586 (C‚S), 1373 (C‚S), 1117, 1092 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.51 (S, 3H, CH3), 6.86–
7.78 (m, 7H, Ar-H), 8.49 (S, 1H, pyran-H), 10.04 (S, 1H,
NH), 11.08 (S, 1H, NH). MS: m/z (%) 374.3 (M++1,
100%) base peak, 375.3 (M++2, 42%). Elemental analysis:
Calc. for C18H13F2N3O2S (373.38) C, 57.90%; H, 3.51%; N,
11.25%; S, 8.59%, found: C, 57.79%; H, 3.66%; N, 11.25%;
S, 8.42%.
2.2.16. N-ethyl-2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)
hydrazinecarbothioamide (16)
IR (KBr) cm1: 3414, 3325 (NH), 1728 (C‚O), 1637 (C‚N),
1619, 1583 (C‚S), 1379 (C‚S), 1127, 1090 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.34 (S, 3H, CH3), 2.51 (t,
3H, ethyl-CH3, J= 4.48), 3.37 (S, 1H, NH), 7.18–7.19 (q, 2H,
ethyl-CH2, J= 4.12), 7.2–7.8 (m, 4H, Ar-H), 8.51 (S, 1H,
pyran-H), 10.91 (S, 1H, NH). MS: m/z (%) 290.3 (M++1,
100%) base peak, 291.3 (M++2, 30%). Elemental analysis:t synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimi-
plied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.04.002
Table 1a Reusability profile of SSA and CSA.
Run % Yield of
Product
(SSA)
Recovery of
catalyst (%)
(SSA)
% Yield of
product
(CSA)
Recovery of
catalyst (%)
(CSA)
1 95 99 95 99
2 95 98 94 97
3 93 96 92 95
4 92 94 91 93
Synthesis and evolution of coumarin hybrid thiosemicarbazone derivatives 5Calc. for C14H15N3O2S (289.35) C, 58.11%; H, 5.23%; N,
14.52%; S, 11.08%, found: C, 58.18%; H, 5.34%; N,
14.43%; S, 11.12%.
2.2.17. N-phenyl-2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)
hydrazinecarbothioamide (17)
IR (KBr) cm1: 3416, 3336 (NH), 1724 (C‚O), 1635 (C‚N),
1618, 1582 (C‚S), 1379 (C‚S), 1126, 1098 (CAO). 1H NMR
(400 MHz, DMSO-d6, d ppm, J Hz) 2.35 (S, 3H, CH3), 7.21–
8.09 (m, 10H, Ar-H), 8.50 (S, 1H, pyran-H), 10.15 (S, 1H,
NH), 10.75 (S, 1H, NH). MS: m/z (%) 338.3 (M++1,
100%) base peak, 339.3 (M++2, 28%). Elemental analysis:
Calc. for C18H15N3O2S (337.4) C, 64.08%; H, 4.48%; N,
12.45%; S, 9.50%, found: C, 64.18%; H, 4.50%; N, 12.33%;
S, 9.51%.
2.2.18. N-cyclohexyl-2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)
hydrazinecarbothioamide (18)
IR (KBr) cm1: 3417, 3154 (NH2), 3232 (NH), 1724 (C‚O),
1633 (C‚N), 1619, 1582 (C‚S), 1371 (C‚S), 1125, 1099
(CAO). 1H NMR (400 MHz, DMSO-d6, d ppm, J Hz) 1.13–
1.90 (m, 10H, cyclohexyl), 2.51 (S, 3H, CH3), 4.20–4.21 (m,
1H, cyclohexyl), 7.38–7.83 (m, 4H, Ar-H), 8.03 (S, 1H,
pyran-H), 8.31(S, 1H, NH), 10.48 (S, 1H, NH). MS: m/z (%)
344.3 (M++1, 100%) base peak, 345.3 (M++2, 38.5%). Ele-
mental analysis: Calc. for C18H21N3O2S (343.14) C, 62.95%;
H, 6.16%; N, 12.23%; S, 9.34%, found: C, 62.82%; H,
6.03%; N, 12.17%; S, 9.08%.
2.2.19. 2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)
hydrazinecarbothioamide (19)
IR (KBr) cm1: 3419, 3152 (NH2), 3230 (NH), 1720 (C‚O),
1630 (C‚N), 1613, 1588 (C‚S), 1375 (C‚S), 1120, 1095
(CAO). 1H NMR (400 MHz, DMSO-d6, d ppm, J Hz) 2.26
(S, 3H, CH3), 7.38–7.77 (m, 4H, Ar-H), 7.99 (S, 1H, pyran-
H), 8.47 (S, 2H, NH2), 10.49 (S, 1H, NH). MS: m/z (%)
262.2 (M++1, 100%) base peak. Elemental analysis: Calc.
for C12H11N3O2S (261.30) C, 55.16%; H, 4.24%; N, 16.08%;
S, 12.27%, found: C, 55.11%; H, 4.29%; N, 16.23%; S,
12.16%.
2.3. Biological assay
This work has been done in, Microcare Laboratory and TRC,
Surat, India as per reported method. (Hawkey and Lewis,
2003)
3. Results and discussion
Starch sulfuric acid (SSA) and cellulose sulfuric acid are read-
ily prepared according to previously reported methods, in
which drop wise addition of chlorosulfonic acid to a mixture
of starch or cellulose in n-hexane or in dichloromethane at
0 C was done. It is important to note that this reaction is easy
and clean without any work-up procedure because HCl gas is
evolved from the reaction vessel immediately. This white
homogeneous, nonhygroscopic solid acid is stable under the
reaction conditions.
In the present study 3-acetyl coumarin was synthesized by
the reaction of salicylaldehyde (1 mmol) and ethyl acetoacetatePlease cite this article in press as: Vekariya, R.H. et al., A one pot, three componen
crobial evolution. Journal of the Association of Arab Universities for Basic and Ap(1 mmol) using CSA or SSA (0.004 g) as a catalyst at 100 C
under solvent-free conditions (Scheme 1). The resultant 3-
acetyl coumarin was obtained in 95% yield with high purity
within 4 h. For the optimization of reaction conditions, we
have carried out this synthesis using various solvents such as
methanol, ethanol, chloroform, acetonitrile, ethyl acetate,
dichloromethane, tetrahydrofuran (THF), dimethylformamide
(DMF) and water as well as in solvent-free conditions. How-
ever, best results were obtained in solvent-free conditions in
terms of product yield and reaction time. In most of previously
reported methods, the reaction afforded comparatively lower
product yield and also was done under some toxic and haz-
ardous conditions. Thus, SSA and CSA promoted the reac-
tions more effectively than the other catalysts and should be
considered as one of the best choices for selecting an econom-
ically convenient, user friendly catalyst. One of the beneficial
advantages of these catalysts was that they could be recovered
and reused several times without loss of their efficiency. SSA
and CSA were recovered by filtration after the addition of
ethanol to the stirred reaction mixture. For reusability experi-
ments, recovered catalyst was dried in an oven at 80 C for 1 h
prior before use. The results, given in (Table 1a), indicate the
catalyst was reusable four times without any significant loss
of activity. We have also tested this reaction with different
loading of SSA and CSA at 100 C. However, 0.004 g. catalyst
(SSA or CSA) was sufficient for this conversion, this happened
because 0.004 g. of catalyst is enough to carry out this trans-
formation in the forward direction (Table 1b, Fig. 2).
To recognize the optimization of the reaction conditions,
the reaction was studied by employing several catalysts and
solvents as well as under solvent-free conditions with the hope
to maximize the product yield in short reaction times (Table 2).
Initially, isothiocyanatobenzene (1.0 mmol), hydrazine hydrate
(1.5 mmol, 80%) and 3-acetyl coumarin (1.0 mmol) were
refluxed in the presence of ethanol as the solvent without
any catalyst, however, the reaction, even after 12 h, only
22% product was obtained (Table 2, Entry 1). Then the reac-
tion was carried out in ethanol in the presence of p-
toluenesulphonic acid (p-TSA) under reflux conditions for
6 h and the product was isolated in 66% yield (Table 2, Entry
2). In continuation, we have also carried out the same reaction
using p-TSA for 8 h and 12 h, but no effective change in result
was obtained (Table 2, Entries 3 and 4), while a similar reac-
tion was carried out in the water, which did not give any
improved results and only 42% product was isolated (Table 2,
Entry 5). The reactions were also restrained from using
hydrochloric acid (HCl) and formic acid as catalysts in ethanol
and water, but they didn’t give satisfactory results (Table 2,
Entries 6–9). Lewis acid catalyst like Cu(OAc)2was tested int synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimi-
plied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.04.002
Table 1b Screening of load of catalysts on % yield of 3-acetyl
coumarin.
Entry Catalyst Amount of catalyst (g) Time (h) Yield (%)a
1 SSA 0.001 4 62
2 SSA 0.002 4 74
3 SSA 0.003 4 82
4 SSA 0.004 4 95
5 SSA 0.005 4 95
6 CSA 0.004 4 95
7 CSA 0.003 4 84
8 CSA 0.005 4 95
a All reactions were carried out at 100 C.
Table 2 Screening of catalysts and solvents and reaction
conditions.
Entry Conditions Solvent Catalyst Time
(h)
Yield
(%)a,b
1 Reflux Ethanol – 12 22
2 Reflux Ethanol p-TSA 6 66
3 Reflux Ethanol p-TSA 8 70
4 Reflux Ethanol p-TSA 12 72
5 Reflux Water p-TSA 12 42
6 Reflux Ethanol HCl 6 62
7 Reflux Water HCl 6 45
8 Reflux Ethanol HCOOH 6 38
9 Reflux Water HCOOH 6 28
10 Reflux Ethanol Cu(OAc)2 6 Trace
c
11 Reflux Ethanol Gl. AcOH
(20 mol%)
4 92
12 Reflux Methanol Gl. AcOH
(20 mol%)
4 84
13 Reflux Water Gl. AcOH
(20 mol%)
4 46
14 Reflux CHCl3 Gl. AcOH
(20 mol%)
4 34
15 Reflux Toluene Gl. AcOH
(20 mol%)
4 38
16 Reflux Ethyl
acetate
Gl. AcOH
(20 mol%)
4 41
17 Reflux Acetonitrile Gl. AcOH
(20 mol%)
4 47
18 Reflux Ethanol Gl. AcOH
(5 mol%)
6 62
19 Reflux Ethanol Gl. AcOH
(7.5 mol%)
6 68
20 Reflux Ethanol Gl. AcOH
(10 mol%)
4 76
21 Reflux Ethanol Gl. AcOH
(15 mol%)
4 80
22 Reflux Ethanol Gl. AcOH
(25 mol%)
4 92
a All reactions were carried out with isothiocyanatobenzene
(1.0 mmol), hydrazine hydrate (1.5 mmol, 80%) and 3-acetyl cou-
marin (1.0 mmol).
b Yield of isolated product.
c Reaction failed to provide trace amount of product.
6 R.H. Vekariya et al.ethanol and provided a trace amount of the desired product
(Table 2, Entry 10). We then applied glacial acetic acid
(AcOH) (20 mol%) as catalyst in ethanol, methanol and water
respectively (Table 2, Entries 11–13), eventually we achieved
satisfaction because the reaction proceeded well, affording
the desired product in good yield. We have also, carried out
this reaction using various solvents like toluene, ethyl acetate,
acetonitrile, chloroform (Table 2, Entries 14–17). However,
ethanol was the best solvent for this transformation in terms
of the yield of the product and times of the reaction.
From the experiments to optimize reaction conditions, we
have taken glacial acetic acid (AcOH) as a catalyst for these
transformations. Then we concentrated our consideration on
generalizing the promising conditions for the reaction. For
that we scanned different amounts of glacial acetic acid. The
use of 5 mol%, 7.5 mol%, 10 mol% and 15 mol% glacial
AcOH was affected on the% yields of the product (Table 2,
Entries 18–21), which intended that the quantity of the catalyst
had a large effect on the formation of the desired product in
excellent yield. In addition, no improved result was obtained,
when we used 25 mol% glacial AcOH (Table 2, Entry 22).
We employed a wide range of aliphatic and aromatic isoth-
iocynates to evaluate the generalization of this protocol. The
reaction progressed smoothly and provided excellent yields in
all cases (Table 3). Both electron-withdrawing and electron-
donating substituents of isothiocynates reacted smoothly with
this protocol to afford excellent yields of the products. The
reactions were also carried out scaled up to the 10 mmol scale
and it is interesting to note that all results were observed cor-
respondingly similar to the 1 mmol scale. Furthermore, all syn-
thesized products were easily purified by recrystallization from
ethanol, thus avoiding extraction steps and chromatographic
separations. The purity of the synthesized compounds was
confirmed by TLC and elemental analysis.0
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Figure 2 Screening of amount of SSA and CSA.
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crobial evolution. Journal of the Association of Arab Universities for Basic and ApThe structure of the final products were well characterized
by using spectral (IR, 1H NMR and HRMS) and elemental
analysis data (ESI). IR spectra showed characteristic peaks
of these derivatives with 3300–3500 cm1 corresponding to
amidic NH, while 1710–1735 cm1 exhibited the cyclic ester
of the coumarin nucleus and another, observed between,
1050 and 1150 cm1, was assigned to CAO stretching fre-
quency. The 1H NMR spectrum of DMSO exhibited a singlet
nearer 10 ppm, which was attributed to the ANH group,
another characteristic peak of these derivatives showed nearer
to 8.5 ppm, which indicated a proton of the pyran nucleus.
Peaks between 7.05 and 8.70 ppm were observed for respective
aromatic protons. The ESIMS spectra of compounds (1–19),
show corresponding (M++1) peak and (M++2) peak in the
case of bromo and chloro substituted compounds.
We hypothesized that mechanistically the reaction proceeds
through the addition reaction between isothiocynate and
hydrazine hydrate, which is very fast and produced thiosemi-
carbazide in excellent yields. Now, in the second step a lonet synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimi-
plied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.04.002
Table 3 One-pot solvent free synthesis of coumarin hybrid thiosemicarbazone derivatives (1–19).
Compound code R Time (h) % Yielda % Yieldb M.P. (C)
1
O2N
4 85 77 192–194
2
Cl
3.5 92 85 184–186
3
H3C
3.0 88 81 197–199
4 3.5 85 77 284–285
5 Cl
Cl
4.0 89 80 203–205
6 3.0 84 76 190–192
7 3.5 85 77 88–90
8
MeO
4.0 91 82 285–287
9
I
3.5 92 84 180–182
10
Cl
Cl
4.0 87 77 215–217
11
OMe
3.5 91 85 196–198
12
OMe
3.5 90 80 202–204
13 Cl
Cl
Cl
4.0 88 81 187–189
14
Cl Cl
4.0 84 77 181–183
15
F F
4.0 88 79 186–188
16 3.0 87 78 293–295
17 4.0 92 86 183–185
18 3.5 91 88 163–165
19 H 4.0 94 87 216–218
a Yield of the isolated product.
b Yield of the purified product.
Synthesis and evolution of coumarin hybrid thiosemicarbazone derivatives 7pair of electrons present on the primary amine of thiosemicar-
bazide attacks the carbo-cation of the 3-acetyl group of
coumarin, at a time when proton transfer occurs from nitrogen
to oxygen. This process occurred due to the presence of acetic
acid as the catalyst, because acetic acid pulls the electron from
the carbonyl group of 3-acetyl to form the reactive carbo-
cation. The third step is dehydrogenation, in which the proton
from nitrogen and hydroxy groups at carbon are situated at
adjacent positions. Thus, removal of water molecule occurred
from them to form the thiosemicarbazone derivative (Fig. 3).Please cite this article in press as: Vekariya, R.H. et al., A one pot, three componen
crobial evolution. Journal of the Association of Arab Universities for Basic and Ap4. Biological evaluation
All newly synthesized coumarin hybrid thiosemicarbazone
derivatives (1–19) were examined for antimicrobial activity
against two gram-positive bacterial strains (Staphylococcus
aureus MTCC 96, Streptococcus pyogenes MTCC 442), two
gram-negative bacterial strains (Escherichia coli MTCC 443,
Pseudomonas aeruginosa MTCC 1688) as well as three fungal
strains (Aspergillus clavatus MTCC 1323, Candida albicans
MTCC 227 and Aspergillus niger MTCC 282) using the agart synthesis of coumarin hybrid thiosemicarbazone derivatives and their antimi-
plied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.04.002
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Figure 3 Proposed reaction mechanism.
8 R.H. Vekariya et al.dilution method (Hawkey and Lewis, 2003). Ampicillin, Cipro-
floxacin and Chloramphenicol were used as standard control
drugs for antibacterial activity, whereas Nystatin and Greseo-
fulvin were used as standard control drugs for antifungal
activity.
4.1. In vitro antibacterial activity
Reviewing the antibacterial activities of coumarin hybrid
thiosemicarbazone derivatives (Table 4) indicates that all scaf-
folds were found to exhibit good to moderate activity against
the specific microbial strain. Table 4 shows that bioassay
results of the series of (1–19) compounds revealed that com-
pound 15, bearing an electron deactivating fluoro group at 2
and 4 positions of the phenyl ring, was found to be the most
active compound that inhibits the gram positive S. aureusTable 4 In-vitro antibacterial activity of compounds (1–19).
MIC [lg/mL]
Sr. No. Compound code E. coli MTCC 443 P. aeruginosa
1 1 100 100
2 2 62.5 200
3 3 100 125
4 4 200 200
5 5 62.5 125
6 6 250 200
7 7 100 125
8 8 62.5 100
9 9 100 200
10 10 62.5 100
11 11 125 200
12 12 200 200
13 13 62.5 100
14 14 62.5 125
15 15 50 100
16 16 100 250
17 17 250 250
18 18 100 100
19 19 62.5 100
20 Ampicillin 100 100
21 Ciprofloxacin 25 25
22 Chloramphenicol 50 50
Please cite this article in press as: Vekariya, R.H. et al., A one pot, three componen
crobial evolution. Journal of the Association of Arab Universities for Basic and Apbacterial growth at the lowest minimum inhibitory concentra-
tion (MIC) value of 50 lg/mL. Compounds 2, 5, 10 and 13
with a chloro group on the phenyl ring showed excellent effec-
tiveness with 125 lg/mL MIC against the same bacteria, while
compound 14 exhibited more potent activity with 100 lg/mL
MIC against the same bacteria. Interestingly, compound 4
having a propyl aliphatic linker, inhibits the both gram posi-
tive S. aureus and S. pyogenus bacterial growth at the lowest
minimum inhibitory concentration (MIC) value of 100 lg/
mL. Similarly compounds 2, 5, 8, 10, 13, 14 and 19 exhibited
high potent activity against E. coli at MIC of 62.5 lg/mL,
while compound 15 showed more potent activity against E.
coli equivalent to Chloramphenicol. Here, compound 8 having
an electron donating substituent like OMe on the phenyl ring
inhibits the gram negative E. coli bacterial growth at the lowest
minimum inhibitory concentration (MIC) value of 62.5 lg/
mL. Furthermore, compounds 1, 8, 10, 13, 15, 18 and 19
showed good activity against gram negative P. aeruginosa
equivalent to Chloramphenicol. Here, Compound 18 has an
aliphatic cyclohexyl ring, while compound 19 has no sub-
stituents. Surprisingly, compound 1, bearing an electron with-
drawing nitro group on the phenyl ring, was found to be the
active one that inhibits gram negative P. aeruginosa and gram
positive S. pyogenus bacterial growth at the minimum inhibi-
tory concentration (MIC) value of 100 lg/mL equivalent to
Ampicillin. Compounds 1, 3, 4, 6, 7, 13, 14 and 15 exhibited
good activity against gram positive S. pyogenus bacterial
growth at the minimum inhibitory concentration (MIC) value
of 100 lg/mL equivalent to Ampicillin. It is important to note
that compound 4, 6 and 7, bearing aliphatic linker substituents
shows good activity against gram positive S. pyogenus bacte-
ria. It can be noted that among the halogenated compounds
with the lowest lipophilicity (Lowest Log P) showed highest
activity against bacteria.MTCC 1688 S. aureus MTCC 96 S. pyogenus MTCC 442
250 100
125 250
250 100
100 100
125 250
200 100
200 100
250 250
250 500
125 250
250 200
250 250
125 100
100 100
50 100
500 500
250 250
500 500
500 500
250 100
50 50
50 50
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Table 5 In-vitro antifungal activity of compounds (1–19).
MIC [lg/mL]
Sr.
No.
Compound
code
C. albicans
MTCC 227
A. niger
MTCC 282
A. clavatus
MTCC 1323
1 1 500 1000 1000
2 2 250 250 250
3 3 1000 1000 1000
4 4 1000 500 500
5 5 250 250 250
6 6 500 500 500
7 7 250 1000 >1000
8 8 500 >1000 >1000
9 9 250 1000 1000
10 10 250 250 250
11 11 500 250 250
12 12 500 1000 >1000
13 13 250 250 250
14 14 250 250 250
15 15 100 100 100
16 16 250 1000 >1000
17 17 1000 500 500
18 18 500 1000 1000
19 19 >1000 1000 500
20 Nystatin 100 100 100
21 Greseofulvin 500 100 100
Synthesis and evolution of coumarin hybrid thiosemicarbazone derivatives 94.2. In vitro antifungal activity
Antifungal activity data (Table 5) showed that among the (1–
19) analogs, compound 15 bearing an electron deactivating flu-
oro group at 2 and 4 positions of the phenyl ring displayed
excellent activity at 100 lg/mL MIC against C. albicans equiv-
alent to Nystatin and greater then Greseofulvin, whereas com-
pounds 2, 5, 10, 13 and 14 with a chloro substituent on the
phenyl ring also showed excellent activity at 250 lg/mL MIC
against C. albicans fungi. In addition, compounds 7 and 16
with aliphatic substituents also exhibited potent activity at
250 lg/mL MIC against C. albicans fungi. Compound 9, bear-
ing an Iodo substituent at the para position of phenyl ring
demonstrated superior activity at 250 lg/mL MIC against C.
albicans. Analogues 1, 6, 8, 11, 12, 18 exhibited good activity
against C. albicans fungi at 500 lg/mL equivalent to Greseo-
fulvin. Moreover, compounds (1–19) exerted moderate inhibi-
tory efficiency against the A. niger and A. clavatus. Only
Compound 15, displayed excellent activity at 100 lg/mL
MIC against A. niger and A. clavatus fungi, which is equivalent
to Nystatin.
5. Conclusion
In this article, we have presented the initial efforts made
toward the discovery of novel, potentially active 2-(1-(2-oxo-
2H-chromen-3-yl)ethylidene)hydrazinecarbothioamide deriva-
tives. These derivatives were prepared through one-pot three
component reaction of isothiocynates, hydrazine hydrate and
3-acetyl-2H-chromen-2-one in the presence of a catalytic
amount of glacial acetic acid in refluxing ethanol. We have also
reported an environmentally friendly synthesis of 3-acetyl-2H-
chromen-2-one using starch sulfuric acid and cellulose sulfuric
acid as a biodegradable catalyst by the reaction ofPlease cite this article in press as: Vekariya, R.H. et al., A one pot, three componen
crobial evolution. Journal of the Association of Arab Universities for Basic and Aportho-hydroxy benzaldehyde and ethyl acetoacetate under
solvent-free conditions. From the bioassays it is clear that
the hybridization of coumarin nuclei with different thiosemi-
carbazides leads to more active antimicrobial as well as anti-
fungal activity. In the present study, compound 2, 4, 5, 10,
13, 14 and 15 exhibited highly potent activity against most
of the tested bacteria.
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